title: Treatment of peritoneal dialysis related peritonitis--an Australian and New Zealand perspective.
authors.affiliation: St Vincent's Hospital, Melbourne, Vic.
authors.forename: B F
authors.initials: BF
authors.lastname: Murphy
authors.forename: D C
authors.initials: DC
authors.lastname: Harris
authors.forename: A
authors.initials: A
authors.lastname: Disney
authors.forename: L S
authors.initials: LS
authors.lastname: Ibels
authors.forename: D
authors.initials: D
authors.lastname: Saltissi
authors.forename: R
authors.initials: R
authors.lastname: Rigby
authors.forename: M
authors.initials: M
authors.lastname: Suranyi
authors.forename: J
authors.initials: J
authors.lastname: Collins
mesh_terms: D000465:Algorithms; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001315:Australia; D002404:Catheterization; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D009520:New Zealand; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology; D011552:Pseudomonas Infections / Q000628:therapy; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D014640:Vancomycin